Mass population vaccination for COVID-19 in Malta #MMPMID33973833
Grech V; Souness J; Agius S
J Vis Commun Med 2021[Oct]; 44 (4): 181-187 PMID33973833show ga
INTRODUCTION: COVID-19 remains pandemic with countries scrambling to mass vaccinate populations, prioritising health-care workers, the elderly and the vulnerable. Malta is a small Mediterranean country with a population of circa half a million with free healthcare at point-of-care. This paper reviews the adaptations made to cope with mass vaccination. METHODS: Permission was obtained to tour hospital facilities. Photographs were taken with and edited on a mobile phone, a previously utilised methodology. RESULTS: Vaccination commenced on 27/12/20 with priorities as above. Malta Medical School lecture halls were initially used, followed by outpatients at the country's regional hospital, as well as other lecture halls, and National Health Service clinics. Virtually all medically vulnerable individuals have had their first doses as well as most individuals >/=60 years of age, with the 55-60 year age group currently targeted. Malta is well ahead of the European Union average. DISCUSSION: Exacting logistics and cooperation by all local authorities (such as the University of Malta) has resulted in a highly successful vaccine rollout. The eventual licencing of vaccination for children and the availability of booster dose/s will further facilitate the eventual attainment of herd immunity. This must be a global effort lest escape variants render these efforts futile.
J+Vis+Commun+Med 2021 ; 44 (4): 181-187
